疫苗前沿 | 新冠爆发不到两年就获批！首款口服抗新冠病毒疗法诞生记

 

参考资料：

[1] Merck and Ridgeback’s Molnupiravir, an Oral COVID-19 Antiviral Medicine, Receives First Authorization in the World. Retrieved November 4, 2021, from https://www.merck.com/news/merck-and-ridgebacks-molnupiravir-an-oral-covid-19-antiviral-medicine-receives-first-authorization-in-the-world/

[2] First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA. Retrieved November 4, 2021, from https://www.gov.uk/government/news/first-oral-antiviral-for-covid-19-lagevrio-molnupiravir-approved-by-mhra

[3] How antiviral pill molnupiravir shot ahead in the COVID drug hunt. Retrieved November 4, 2021, from https://www.nature.com/articles/d41586-021-02783-1

打赏